Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Stone Age to \|/ Stone

One question I have for management is why in the world would you spend millions of dollars in the name of "advertising" and goo gobs of "infomercials" with the CEO's face plastered everywhere on the website in support of such infomercials (reminder of the spend rate) and the stock only continues to veer towards new all time lows at every turn? Ok, so now management made it's pitch and delivery on moving to Nasdaq with the belief the company will be exposed to a better classroom investors. Given that execution, what roll should their website play in the grand scheme of things?

Business 101 suggests you can drive more eyes to your website with the minimalist number of characters. 14 characters or less is the best target zone to accomplishing maximum drive/traffic. Therefore, why didn't management secure the most obvious website for the company moving forward with the rebranding of the company in 2018? Moreau spewed reels of infomercial stories about how he came up with the Algernon name and how he needed to convince Dr. Mark Williams (The Brainchild of All Things in Algernon's Pipeline Portfolio) it was a good idea. Ok, but again why did you not think or think at all it was a good idea to secure the shorter and more desirable domain name for the company from the outset for $10 freaking dollars! If you go out to Algernon's Twitter page the first thing you will see below the corporate logo at the top of the page is "[e-mail]". Do you see where the Pharma is abbreviated there? Surely, it proves a shorter version of the word Pharma is more desirable in their minds eye. Think of how hard is is for some to correctly spell the name Algernon and then how much harder it's likely to spell Pharmaceuticals. You have two words combined that are both hard to spell and twice as challenging for the average speller. There could be an argument made for Algernon not being hard to find on the web, but I'd contribute that to it currently being zero competitive traffic for the better version of a corporate domain name - algernonpharma.com.
The company has no control over that more effective version and what could be potentially trafficked to that website if it every becomes active on the web. If it were to become a space that is not complimentary to Algernon's corporate narrative I could see that posing legal expenses that surely would not be cheap. Thus, management needs to seriously consider what they want to control for it's messaging to the masses and the cost to doing their homework now versus compounding after the fact actions not in their favor.

Here's something else I found interesting in the world wide web realm. Algernon will list at nasdaq with a new abbreviated version of it's stock ticker. From AGNPF to AGNP. Less is better! Now do a web search for AGNP.com. What I gather is someone is targeting a specific company to buy their domain name at a price that suggests they mean business and have done their potential homework an advance of the offering. I firmly believe it has absolutely nothing to do with Algernon Pharmaceuticals but who knows? The bottom line is management need not be hardheaded and stubborn for fumbling the ball in regards to completely missing the mark for securing domain names (they should have secured both long and short version) from the outset. Moreau should check his pride at the door and do what needs to be done in this regard. They've already spending money on "ads" like drunken sailors. Make a real difference with your 21st Century Corporate B R A N D I N G. The better domain name is just Business 101. Management needs more savvy people for the upkeep of their corporate website/image.

Mark this post.

M$